Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG and Plasma Amyloid in Non-Demented Adults
NCT04449926Phase 2Completed
- Sponsor
- Mindful Diagnostics and Therapeutics, LLC
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in Alzheimer's disease (AD), sponsored by Mindful Diagnostics and Therapeutics, LLC. Started Nov 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04449926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449926.